Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (918)
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
96,400
Price
$89.44
Total Value
$8.62M
Shares Held After
505,077
% of Holdings
16.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$531.83
Total Value
$106.37K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,201
Price
$530.84
Total Value
$637.54K
Shares Held After
324,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,279
Price
$529.86
Total Value
$1.21M
Shares Held After
325,844
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,133
Price
$529.08
Total Value
$1.13M
Shares Held After
328,123
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,989
Price
$527.77
Total Value
$1.05M
Shares Held After
330,256
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$526.88
Total Value
$290.84K
Shares Held After
332,245
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
387
Price
$525.83
Total Value
$203.50K
Shares Held After
332,797
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
171
Price
$524.86
Total Value
$89.75K
Shares Held After
333,184
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
339
Price
$523.72
Total Value
$177.54K
Shares Held After
333,355
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
249
Price
$522.87
Total Value
$130.19K
Shares Held After
333,694
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
59,880
Price
$9.96
Total Value
$596.40K
Shares Held After
17,242,483
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
162,500
Price
$21.25
Total Value
$3.45M
Shares Held After
574,047
% of Holdings
22.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
162,500
Price
$21.25
Total Value
$3.45M
Shares Held After
574,054
% of Holdings
22.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,669
Price
$325.00
Total Value
$542.42K
Shares Held After
0
% of Holdings
100.0%
Shares
38,016
Price
$1.33
Total Value
$50.48K
Shares Held After
3,337,648
% of Holdings
1.1%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
8,111
Price
$11.25
Total Value
$91.25K
Shares Held After
148,175
% of Holdings
5.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
14,562
Price
$89.24
Total Value
$1.30M
Shares Held After
601,477
% of Holdings
2.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
48,032
Price
$88.65
Total Value
$4.26M
Shares Held After
616,039
% of Holdings
7.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
37,406
Price
$87.70
Total Value
$3.28M
Shares Held After
664,071
% of Holdings
5.3%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
84,124
Price
$9.93
Total Value
$835.35K
Shares Held After
17,182,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$539.47
Total Value
$43.16K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$538.46
Total Value
$366.15K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$537.60
Total Value
$306.43K
Shares Held After
325,203
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
790
Price
$536.49
Total Value
$423.83K
Shares Held After
325,773
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
107
Price
$535.40
Total Value
$57.29K
Shares Held After
326,563
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
324
Price
$534.18
Total Value
$173.08K
Shares Held After
326,670
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
489
Price
$533.24
Total Value
$260.76K
Shares Held After
326,994
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$531.22
Total Value
$212.49K
Shares Held After
327,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$529.80
Total Value
$402.64K
Shares Held After
327,883
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
874
Price
$528.91
Total Value
$462.26K
Shares Held After
328,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,211
Price
$527.82
Total Value
$639.19K
Shares Held After
329,517
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,610
Price
$526.84
Total Value
$1.38M
Shares Held After
330,728
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$526.04
Total Value
$255.13K
Shares Held After
333,338
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$524.27
Total Value
$62.91K
Shares Held After
333,823
% of Holdings
0.0%
Greenland Mines Ltd (GRML)
Sawyer Jason David — Director
Shares
240,000
Price
$0.23
Total Value
$55.94K
Shares Held After
240,000
% of Holdings
100.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
120,582
Price
$9.55
Total Value
$1.15M
Shares Held After
17,098,479
% of Holdings
0.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
213,702
Price
$22.12
Total Value
$4.73M
Shares Held After
812,058
% of Holdings
20.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
278,698
Price
$21.72
Total Value
$6.05M
Shares Held After
1,025,760
% of Holdings
21.4%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,438
Price
$26.87
Total Value
$199.89K
Shares Held After
38,400
% of Holdings
16.2%
Rani Therapeutics Holdings, Inc. (RANI)
IMRAN MIR A — Director
Shares
36,000
Price
$0.69
Total Value
$24.84K
Shares Held After
2,119,334
% of Holdings
1.7%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
573
Price
$1.76
Total Value
$1.01K
Shares Held After
82,194
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$80.59
Total Value
$282.06K
Shares Held After
153,902
% of Holdings
2.2%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
250,000
Price
$6.00
Total Value
$1.50M
Shares Held After
1,226,638
% of Holdings
16.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
556
Price
$80.66
Total Value
$44.85K
Shares Held After
701,477
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
74,444
Price
$79.98
Total Value
$5.95M
Shares Held After
702,033
% of Holdings
9.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,340
Price
$320.06
Total Value
$748.94K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,807
Price
$319.29
Total Value
$5.05M
Shares Held After
2,340
% of Holdings
87.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
7,842
Price
$318.41
Total Value
$2.50M
Shares Held After
18,147
% of Holdings
30.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,029
Price
$316.91
Total Value
$6.35M
Shares Held After
25,989
% of Holdings
43.5%
Showing 101–150 of 918 transactions (page 3 of 19)